Securities Code: 688690 Securities Abbreviation: Nanwei Technology Announcement No.: 2021-016

Suzhou Nawei Technology Co., Ltd.

Announcement on the proposed establishment of subsidiaries and the purchase of land use rights

the company's board of directors and all directors to ensure that the contents of this announcement does not exist any false records, misleading statements or major omissions, and the authenticity, accuracy and completeness of the contents of the legal responsibility.

Important Content Tips:

Suzhou Nawei Technology Co., Ltd. (hereinafter referred to as "the company") intends to use its own funds to purchase the land use right of the target plot located in Dushan Port Economic Development Zone, Zhejiang Province, with a total area of about 60 mu (subject to the actual land area). The company intends to set up a wholly-owned subsidiary in Zhejiang Dushan Port Economic Development Zone to be responsible for the specific development and construction of the land and the later operation and management.

The proposed purchase of assets does not constitute a related transaction, nor does it constitute a major asset reorganization.

Special risk reminder: The land use right to be purchased this time needs to be carried out through bidding, auction and listing or other legal methods. Whether the land use right can be obtained, the final transaction price and acquisition time of the land use right are uncertain.

1. the establishment of wholly-owned subsidiaries and assets to be purchased by this foreign investment

In order to ensure the implementation of the company's medium and long-term strategic planning and industrial layout, and effectively expand production capacity, after in-depth communication between the company and the management committee of Zhejiang Dushan Port Economic Development Zone, the company will establish a wholly-owned subsidiary Zhejiang Nawei in the Dushan Port District of Zhejiang in the near future. Biotechnology Co., Ltd. has a registered capital of RMB 0.2 billion, the business scope is the research and development, production, sales and related technical services of chromatographic fillers and chromatography media products (the name and business scope are subject to the review opinions of the competent department for industry and commerce).

In the name of Zhejiang Nawei Biotechnology Co., Ltd., the company intends to use its own funds to purchase the land use right of the target plot located in Dushan Port Economic Development Zone, Zhejiang Province, with a total area of about 60 mu.

This matter has been reviewed and approved at the fifth meeting of the second board of directors of the company. After internal calculation, it is expected that the transfer price of the land use right of the target land and the establishment of the wholly-owned subsidiary will be within the approval authority of the board of directors, and there is no need to mention it.

to the general meeting of shareholders of the company for consideration. The proposed purchase of assets does not involve connected transactions, nor does it constitute a major asset reorganization as stipulated in the Measures for the Administration of Major Asset Reorganization of Listed Companies and the Special Provisions on Major Asset Reorganization of Listed Companies on the Science and Technology Innovation Board.

2. the impact of the proposed asset purchase on the Company

The company plans to set up a wholly-owned subsidiary in Zhejiang Dushan Port Economic Development Zone to be responsible for the specific development and construction of the land and the later operation and management. The purchase of land use rights is in line with the company's reasonable planning for capacity growth, which can better meet the requirements of biopharmaceuticals for the stable supply of key production consumables, enhance the company's market competitiveness, and benefit the company's strategic development planning goals. The purchase of land use rights will not affect the normal development of the company's existing main business, will not have a significant impact on the company's financial situation and operating results, there is no harm to the interests of listed companies and all shareholders.

3. Risk Alert

The land use right to be purchased this time needs to be carried out through bidding, auction and listing or other legal means, and there is uncertainty about whether the land use right can be obtained, the final transaction price and the time of acquisition. Please the majority of investors rational investment, pay attention to investment risk.

It is hereby announced.

Board of Directors of Suzhou Nawei Technology Co., Ltd.

December 27, 2021